Skip to main content
Clinical Trials/NCT03522766
NCT03522766CompletedNot Applicable

Evaluation of Urine Samples and Their Relation to Urinary Tract Infection

Coloplast A/S1 site in 1 country30 target enrollmentStarted: March 19, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Type of bacteria present in the urine

Study Overview

Brief Summary

The aim is to explore the human urine composition and its relation to urine tract infections

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Have given written informed consent
  • Be at least 18 years of age and have full legal capacity
  • For the 2 patient populations: Use intermittent catheter on a daily basis due to neurogenic bladder or enlarged prostate and have used IC for at least 2 months
  • For healthy volunteers without UTIs: No diag-nosed UTIs within the last year
  • For healthy volunteers with recurrent UTIs: 3 or more UTIs within the last year or 2 UTIs within the last 6 months (treated with antibiotics)

Exclusion Criteria

  • Be treated for urinary tract infection at time of enrolment
  • May not take prophylactic treatment for urinary tract infections (antibiotics only)

Outcomes

Primary Outcomes

Type of bacteria present in the urine

Time Frame: 1 year

The different bacteria isolated present in the urine will be identified

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials